Literature DB >> 27769862

miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog.

Mingjun Bi1, Wei Chen2, Hongmei Yu3, Jinxiu Wang1, Fang Ding3, Dong Jing Tang3, Cuiyan Tang3.   

Abstract

MicroRNAs (miRNAs) play important roles in the pathogenesis of many types of cancers by negatively regulating gene expression at posttranscriptional level. Here, we identified that miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer (NSCLC) patients comparing gefitinib-sensitive ones. It promotes NSCLC cell proliferation by negatively regulates its target gene PTEN. In NSCLC cell lines, CCK-8 proliferation assay indicated that the cell proliferation is promoted by miR-543 mimics. Transwell assay showed that miR-543 mimics promotes the invasion and migration of NSCLC cells. Luciferase assays confirmed that miR-543 directly binds to the 3'untranslated region of PTEN, and western blotting showed that miR-543 suppresses the expression of PTEN at the protein level. This study indicates that miR-543 promotes proliferation and invasion of NSCLC cell lines by PTEN. The miR-543 may represent a potential therapeutic target for gefitinib-resistant NSCLC intervention.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Gefitinib; NSCLC; PTEN; miR-543

Mesh:

Substances:

Year:  2016        PMID: 27769862     DOI: 10.1016/j.bbrc.2016.10.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  miR-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the JAM-A.

Authors:  Xue Jiang; Baoqiang Dai; Lichun Feng
Journal:  Hum Cell       Date:  2019-08-19       Impact factor: 4.174

2.  TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.

Authors:  Shuwei He; Xu Wang; Jingjing Zhang; Fan Zhou; Lei Li; Xingmin Han
Journal:  Cell Cycle       Date:  2020-07-02       Impact factor: 4.534

Review 3.  Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer.

Authors:  Antoine Legras; Nicolas Pécuchet; Sandrine Imbeaud; Karine Pallier; Audrey Didelot; Hélène Roussel; Laure Gibault; Elizabeth Fabre; Françoise Le Pimpec-Barthes; Pierre Laurent-Puig; Hélène Blons
Journal:  Cancers (Basel)       Date:  2017-08-03       Impact factor: 6.639

4.  MiR-543 promotes cell proliferation and metastasis of renal cell carcinoma by targeting Dickkopf 1 through the Wnt/β-catenin signaling pathway.

Authors:  Zhi-Yuan Chen; Yang Du; Lei Wang; Xiu-Heng Liu; Jia Guo; Xiao-Dong Weng
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

5.  Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway.

Authors:  Gang Liu; JianPing Zhou; Ming Dong
Journal:  Biosci Rep       Date:  2019-03-22       Impact factor: 3.840

Review 6.  Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients.

Authors:  Martyna Parol; Arkadiusz Gzil; Magdalena Bodnar; Dariusz Grzanka
Journal:  J Transl Med       Date:  2021-01-07       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.